Shawn Cline Tomasello - Director at Kalaris Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
KLRS on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Shawn Cline Tomasello since 15 Aug 2025

Reported holdings for Shawn Cline Tomasello in Kalaris Therapeutics, Inc.

Form 4 holding Director

Allovir, Inc.

Security class
Common Stock
Shares / value
70,000
Estimated value
$55,461
Report date
06 Jun 2024
Price
$0.7923
Ownership
Direct

Transaction history for Shawn Cline Tomasello in Kalaris Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .